CD8A and neoplasm: Therefore, RNase1 should promote a state of T‐cell exhaustion and impair T‐cell activation and effector function to inhibit CD8+ T‐cell cytotoxicity, thereby promoting tumor growth, which we observed in this study (Figure 2J and Figure 6O).